Skip to main content
. Author manuscript; available in PMC: 2017 Aug 22.
Published in final edited form as: J Biopharm Stat. 2016 Aug 22;26(6):1083–1097. doi: 10.1080/10543406.2016.1226335

Table 3.

Parameters of the Diagnostic Yield Table.

Disease Status + + Δ+ Δ
Absent p0ξ0 p0τ0 p0(τ0ξ0) p0(1 − ξ0) p0(1 − ξ0) p0(τ0ξ0)
Present p1ξ1 p1τ1 p1(τ1ξ1) p1(1 − ξ1) p1(1 − τ1) p1(τ1ξ1)
Ratio
θ1-1
θ1−1
re-1
θ1-1
θ0−1
re-1
Adverse events among subjects falsely testing positive:
FP AEs αp0ξ0 αp0τ0 αp0(τ0ξ0)
ΔFP AEs/ΔTP
αre-1

pd = Pr(D = d)

τd = Pr(T = 1|D = d)

ξd = Pr(S = 1|D = d)

Ps=Pr(D=1S=s);θs=Ps/(1-Ps)=oddsofdiseasegivenS=s, s = 0,1

Pt = Pr(D = 1|T = t); θt = Pt/(1 − Pt) = odds of disease given T= t, t = 0,1

re = p1(τ1ξ1)/p0(τ0ξ0) = ratio of relative importance FP:FN or cost benefit C:B at which tests S and T have the same expected utility.

α = Pr(AE|Treat) = risk of adverse event during subsequent management of a test positive subject.